Skip to main content

Regencell Bioscience Holdings Ltd

RGC
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
SEC CIK
0001829667

No open-market purchases or sales by Regencell Bioscience Holdings Ltd insiders were filed in the last 90 days; 35 institutions reported holding it in 13F filings for Q2 2026, worth $8.56M in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding Regencell Bioscience Holdings Ltd changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of RGC: Q4 2025 compared with Q1 2026
MeasureQ4 2025Q1 2026Change
Holders1731+14
Shares548.4K647.2K+98.8K (+18.0%)
Value$11.5M$16.5M+$4.94M (+42.9%)

New holders (18)

Institutions that held Regencell Bioscience Holdings Ltd at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to RGC in Q1 2026
InstitutionSharesValue% of portfolio
Marex Group plc31,600$803.6K0.01%
Gsa Capital Partners LLP31,569$803.0K0.05%
State Street Corp11,851$301.4K0.00%
Legal & General Group Plc9,903$251.8K0.00%
LPL Financial LLC8,596$218.6K0.00%
Amundi8,595$218.6K0.00%
Federation des caisses Desjardins du Quebec2,231$56.7K0.00%
GF Fund Management Co. Ltd.1,064$27.1K0.00%
JPMorgan Chase & Co845$19.7K0.00%
Russell Investments Group, Ltd.760$19.3K0.00%
Group One Trading, L.P.354$9.00K0.00%
Royal Bank of Canada69$2.00K0.00%
Bell Investment Advisors, Inc20$5090.00%
Cornerstone Financial Management LLC15$3810.00%
Bare Financial Services, Inc14$3560.00%
GAMMA Investing LLC8$2030.00%
Citigroup Inc1$250.00%
Tower Research Capital LLC (TRC)1$250.00%

Sold out (4)

Institutions that held Regencell Bioscience Holdings Ltd at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of RGC in Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
XTX Topco Ltd15,081$316.7K
Hudson Bay Capital Management LP13,107$275.2K
Seven Fleet Capital Management LP4,400$92.4K
Quarry LP468$9.83K